From mastering the "neck triangle" to the one-hour rule for vaccines, these 10 simple reminders ensure your spring treatments ...

Gilead’s Tomas Cihlar and his team of researchers have spent decades studying HIV—and their latest innovation could be a game changer for prevention.

Texas medical regulators are gearing up for a major shakeup in how ketamine is used across the state, rolling out proposed ...

A stabilized mRNA carrier turns tumor injection into broader immune activation by extending vaccine delivery to lymph nodes ...

Many farms have detailed treatment protocols in place. However, errors often occur not because protocols are absent, but ...

What do people with migraine hate more than the pain itself? A trip to the emergency room with a migraine attack that won’t stop. Read personal stories from our community and expert tips for avoiding ...

Four Yorktown Secondary School students traveled to Kingsville to earn their Texas Cattle Feeders Association Feedyard ...

A major amendment has prompted the FDA to extend its review of subcutaneous lecanemab as a starting dose for early Alzheimer disease.

Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period ...

This segment discusses the safety and side effect profiles of intravenous and subcutaneous immunotherapy in advanced melanoma ...